Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEAM: FOLFOXIRI/Bevacizumab vs FOLFOX/Bevacizumab in mCRC
NCT01765582Phase 2Terminated
- Sponsor
- Roche
- Start
- Jan 2013
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roche. Started Jan 2013; status: terminated.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01765582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765582.